Immunotec Ranks No. 97 in Sixth Annual DSN Global 100

VAUDREUIL-DORION, QUEBEC--(Marketwired - April 20, 2015) - Immunotec Inc. (TSX VENTURE:IMM), a direct-to-consumer company and a leader in the nutritional industry has been ranked 97^th on the Direct Selling News sixth annual DSN Global 100 list. This list is an exclusive ranking of the top revenue-generating companies in the direct selling industry worldwide.

"We are very pleased to be recognized amongst the Top 100 Direct Selling companies in the world for the first time in Immunotec's history.

This award is the result of the concentrated and consistent efforts of our employees and Independent Sales Consultants around the world. Everyone is very proud of our shared accomplishments which show that we are dedicated to improving people's lives every day.

As we prepare to celebrate our 20^th Anniversary in 2016, we look forward to continuing the momentum that is building within our organization, taking Immunotec to even greater heights." said Charles Orr, CEO

The DSN Global 100 is a collective effort to show the impact and potential of the $178.5 billion direct selling industry. The list, unveiled online at DirectSellingNews.com represents aggregate revenue of $82 billion from companies based in 14 countries.

"The DSN Global 100 ranking is more than a list of who's who and what was accomplished in terms of revenue for the prior year," said John Fleming, Publisher and Editor in Chief of Direct Selling News. "By doing the research and publishing such a list, we spotlight the contributions that the top direct selling companies are making in communities and economies around the world."

This year, DSN introduced a new subset of the Global 100: the North America 50. As its name implies, the North America 50 ranks the most significant players in one of the world's largest direct selling markets. Immunotec ranks No. 48 on the North America 50.

About Direct Selling News

Direct Selling News magazine has been serving direct selling and network marketing executives since 2004. Each issue of DSN offers content on topics that shape the dynamics of the industry, including positive features about the companies that embody the entrepreneurial spirit, in-depth articles on advances in technology and the latest trends, as well as commentary by direct selling executives and experts discussing contemporary issues impacting business.

The Global 100 ranking is based on net revenue before commissions are paid and without any value-added tax. In an effort to support transparency and verify authenticity, DSN requires each company to submit a Revenue Certification Form (RCF) signed by the CEO and CFO or designated agent.

About Immunotec Inc.

Immunotec Inc. is a Canadian-based Company that develops, manufactures, markets and sells research-driven nutritional products through direct-to-consumer sales channels in Canada, the U.S. and Mexico. The Company offers an extensive family of products targeting nutrition, wellness, weight management, as well as energy and fitness. The Immunocal® family of products is supported by over 40 published articles and supporting science in the medical and scientific literature.

The Company files its continuous disclosure documents on the SEDAR database at www.sedar.com and on the Company's website at www.immunotec.com. The common shares of the Company are listed on the TSX Venture Exchange under the ticker symbol IMM. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.